184 related articles for article (PubMed ID: 11351249)
1. Bcl-2 modulates Fas-mediated apoptosis in human renal cell carcinoma cell lines.
Hara I; Hara S; Miyake H; Arakawa S; Kamidono S
Int J Oncol; 2001 Jun; 18(6):1181-5. PubMed ID: 11351249
[TBL] [Abstract][Full Text] [Related]
2. Fas-mediated apoptosis in human prostatic carcinoma cell lines.
Rokhlin OW; Bishop GA; Hostager BS; Waldschmidt TJ; Sidorenko SP; Pavloff N; Kiefer MC; Umansky SR; Glover RA; Cohen MB
Cancer Res; 1997 May; 57(9):1758-68. PubMed ID: 9135020
[TBL] [Abstract][Full Text] [Related]
3. Fas-induced apoptosis of renal cell carcinoma is mediated by apoptosis signal-regulating kinase 1 via mitochondrial damage-dependent caspase-8 activation.
Hassan M; Feyen O; Grinstein E
Cell Oncol; 2009; 31(6):437-56. PubMed ID: 19940360
[TBL] [Abstract][Full Text] [Related]
4. Sodium butyrate induces apoptosis in human renal cell carcinoma cells and synergistically enhances their sensitivity to anti-Fas-mediated cytotoxicity.
Hara I; Miyake H; Hara S; Arakawa S; Kamidono S
Int J Oncol; 2000 Dec; 17(6):1213-8. PubMed ID: 11078807
[TBL] [Abstract][Full Text] [Related]
5. Sensitization of head and neck squamous cell carcinoma cells to Fas-mediated apoptosis by the inhibition of Bcl-X(L) expression.
Otani Y; Tsutsumi K; Kuwahara D; Oyake D; Ohta T; Nishikawa H; Koizuka I
Auris Nasus Larynx; 2003 Feb; 30 Suppl():S79-84. PubMed ID: 12543166
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Bcl-2 protects human hepatoma cells from Fas-antibody-mediated apoptosis.
Takahashi M; Saito H; Okuyama T; Miyashita T; Kosuga M; Sumisa F; Yamada M; Ebinuma H; Ishii H
J Hepatol; 1999 Aug; 31(2):315-22. PubMed ID: 10453946
[TBL] [Abstract][Full Text] [Related]
7. [Resistance to Fas-mediated apoptosis in head and neck squamous cell carcinoma cells].
Otani Y; Kuwahara D; Tsutsumi K
Nihon Jibiinkoka Gakkai Kaiho; 2000 Oct; 103(10):1169-76. PubMed ID: 11109827
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of Bcl-2 sensitises interferon-resistant renal cancer cells to Fas.
Kelly JD; Dai J; Eschwege P; Goldberg JS; Duggan BP; Williamson KE; Bander NH; Nanus DM
Br J Cancer; 2004 Jul; 91(1):164-70. PubMed ID: 15188008
[TBL] [Abstract][Full Text] [Related]
9. Frequent loss of expression of the pro-apoptotic protein Bim in renal cell carcinoma: evidence for contribution to apoptosis resistance.
Zantl N; Weirich G; Zall H; Seiffert BM; Fischer SF; Kirschnek S; Hartmann C; Fritsch RM; Gillissen B; Daniel PT; Häcker G
Oncogene; 2007 Oct; 26(49):7038-48. PubMed ID: 17486061
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of lens epithelial cells by Fas-specific antibody activating Fas-Fas ligand system.
Nishi O; Nishi K; Wada K; Ohmoto Y; Akura J
Curr Eye Res; 2001 Sep; 23(3):192-8. PubMed ID: 11803481
[TBL] [Abstract][Full Text] [Related]
11. Alteration of apoptotic regulatory molecules expression during carcinogenesis and tumor progression of renal cell carcinoma.
Sejima T; Isoyama T; Miyagawa I
Int J Urol; 2003 Sep; 10(9):476-84. PubMed ID: 12941126
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of Fas-mediated apoptosis in renal cell carcinoma cells by adriamycin.
Wu XX; Mizutani Y; Kakehi Y; Yoshida O; Ogawa O
Cancer Res; 2000 Jun; 60(11):2912-8. PubMed ID: 10850437
[TBL] [Abstract][Full Text] [Related]
13. p53 modulation of Fas/Apo-1 mediated apoptosis in a human renal cell carcinoma cell line.
Miyake H; Hara I; Gohji K; Arakawa S; Kamidono S
Int J Oncol; 1998 Feb; 12(2):469-73. PubMed ID: 9458377
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity to Fas-mediated apoptosis in pediatric acute lymphoblastic leukemia is associated with a mutant p53 phenotype and absence of Bcl-2 expression.
Zhou M; Gu L; Yeager AM; Findley HW
Leukemia; 1998 Nov; 12(11):1756-63. PubMed ID: 9823951
[TBL] [Abstract][Full Text] [Related]
15. Antitumor effect of bcl-2 antisense phosphorothioate oligodeoxynucleotides on human renal-cell carcinoma cells in vitro and in mice.
Uchida T; Gao JP; Wang C; Satoh T; Itoh I; Muramoto M; Hyodo T; Irie A; Akahoshi T; Jiang SX; Kameya T; Baba S
Mol Urol; 2001; 5(2):71-8. PubMed ID: 11690551
[TBL] [Abstract][Full Text] [Related]
16. Expression of Apo-1/Fas (CD95), Bcl-2, Bax and Bcl-x in myeloma cell lines: relationship between responsiveness to anti-Fas mab and p53 functional status.
Egle A; Villunger A; Marschitz I; Kos M; Hittmair A; Lukas P; Grünewald K; Greil R
Br J Haematol; 1997 May; 97(2):418-28. PubMed ID: 9163609
[TBL] [Abstract][Full Text] [Related]
17. Resistance to CD95 (APO-1/Fas)-mediated apoptosis in human renal cell carcinomas: an important factor for evasion from negative growth control.
Gerharz CD; Ramp U; Déjosez M; Mahotka C; Czarnotta B; Bretschneider U; Lorenz I; Müller M; Krammer PH; Gabbert HE
Lab Invest; 1999 Dec; 79(12):1521-34. PubMed ID: 10616203
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis induced in human colorectal carcinoma by anti-Fas antibody.
Meterissian SH; Kontogiannea M; Po J; Jensen G; Ferdinand B
Ann Surg Oncol; 1997 Mar; 4(2):169-75. PubMed ID: 9084855
[TBL] [Abstract][Full Text] [Related]
19. Interferon-gamma and anti-Fas antibody-induced apoptosis in human melanoma cell lines and its relationship to bcl-2 cleavage and bak expression.
Kamei T; Inui M; Nakamura S; Okumura K; Goto A; Tagawa T
Melanoma Res; 2003 Apr; 13(2):153-9. PubMed ID: 12690298
[TBL] [Abstract][Full Text] [Related]
20. Apoptotic behaviour of hepatic and extra-hepatic tumor cell lines differs after Fas stimulation.
Lamboley C; Bringuier AF; Feldmann G
Cell Mol Biol (Noisy-le-grand); 2000 Feb; 46(1):13-28. PubMed ID: 10726968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
